Decreased number of FoxP3+ regulatory T cells in preeclampsia

References

• Ghiringhelli F, Menard C, Terme M, Flament C, Taieb J, Chaput N, et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med. 2005; 202: 1075–85
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C, Wolf E, Hafler DA. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+ T cells. Clin Immunol. 2005; 115: 10–8
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity?. Curr Opin Immunol. 2005; 17: 638–42
   PubMed Web of Science ®Google Scholar
• Zenclussen AC. Regulatory T cells in pregnancy. Springer Semin Immunopathol. 2006a; 28: 31–9
   PubMed Web of Science ®Google Scholar
• Paeschke S, Chen F, Horn N, Fotopoulou C, Zambon-Bertoja A, Sollwedel A, et al. Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am J Reprod Immunol. 2005; 54: 384–9
   PubMed Web of Science ®Google Scholar
• Hu D, Chen Y, Zhang W, Wang H, Wang Z, Dong M. Alteration of peripheral CD4+CD25+ regulatory T lymphocytes in pregnancy and preeclampsia. Acta Obstet Gynecol Scand. 2007; 87: 190–4
   Web of Science ®Google Scholar
• Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, et al. Proportion of peripheral blood and decidual CD4+ CD25bright regulatory T cells in preeclampsia. Clin Exp Immunol. 2007; 149: 139–45
   PubMed Web of Science ®Google Scholar
• Darmochwal-Kolarz D, Saito S, Rolinski J, Tabarkiewicz J, Kolarz B, Leszczynska-Gorzelak B, et al. Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol. 2007; 58: 39–45
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299: 1057–61
   PubMed Web of Science ®Google Scholar
• Campbell DJ, Ziegler SF. FoxP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol. 2007; 7: 305–10
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001; 20: IX–XIV
   PubMed Web of Science ®Google Scholar
• Pászthy B, Svec P, Túry F, Kovács L, Vásárhelyi B, Tulassay T, et al. Impact of anorexia nervosa on activation characteristics of lymphocytes. Neuro Endocrinol Lett. 2007; 28: 422–6
   PubMed Web of Science ®Google Scholar
• Svec P, Vásárhelyi B, Pászthy B, Körner A, Kovács L, Tulassay T, et al. Do regulatory T cells contribute to Th1 skewness in obesity?. Exp Clin Endocrinol Diabetes. 2007; 115: 439–43
   PubMed Web of Science ®Google Scholar
• Thuere C, Zenclussen ML, Schumacher A, Langwisch S, Schulte-Wrede U, Teles A, et al. Kinetics of regulatory T cells during murine pregnancy. Am J Reprod Immunol. 2007; 58: 514–23
   PubMed Web of Science ®Google Scholar
• Darmochwal-Kolarz D, Rolinski J, Tabarkiewicz J, Leszczynska-Gorzelak B, Buczkowski J, Wojas K, et al. Myeloid and lymphoid dendritic cells in normal pregnancy and preeclampsia. Clin Exp Immunol. 2003; 132: 339–44
   PubMed Web of Science ®Google Scholar
• Ito T, Yang M, Wang YH, Lande R, Gregorio J, Perng OA, et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med. 2007; 204: 105–15
   PubMed Web of Science ®Google Scholar
• Rusterholz C, Hahn S, Holzgreve W. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol. 2007; 29: 151–62
   PubMed Web of Science ®Google Scholar
• Gleicher N. Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. Am J Obstet Gynecol. 2007; 196: 5.e1–7
   PubMed Web of Science ®Google Scholar
• Gupta S, Joshi K, Wig JD, Arora SK. Intratumoral FoxP3 expression in infiltrating breast carcinoma: its association with clinicopathologic parameters and angiogenesis. Acta Oncol. 2007; 46: 792–7
   PubMed Web of Science ®Google Scholar